Page 21 - Does God News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Offshore wind developer Ørsted has delayed its New Jersey Ocean Wind 1 project to 2026. Previously, the company had announced construction of the project would begin in October 2023. The delay was attributed to supply chain issues, higher interest rates, and a failure so far to garner enough tax credits from the federal government. For now, they are not walking away from all their U.S. projects but will reconsider long-term plans by the end of this year. Ørsted’s stock price has fallen 30% in 5 days. This is just the latest bad news for offshore win.

(NBC NEWS) – Claims processors with the Department of Veterans Affairs say they have strained to keep up with a flood of new cases brought on by the PACT Act and an existing quota system that pits their livelihoods against the veterans they signed up to help as a growing number of the processors leave…

(JUST THE NEWS) – The southern California city of San Diego this week declared a humanitarian crisis as federal authorities continue releasing thousands of illegal immigrants into the city amid a broader surge in border crossings. Migrant shelters in the area have reached their capacities amid the surge in new arrivals, in part driven by…

While Russia has “suspended” its observance of the New START Treaty (clearly in violation of the Treaty), it nonetheless claims that it is continuing to observe its limitations. However, in its annual 2023 report on the New START Treaty, the U.S. Department of State was unable to certify Russian compliance with the numerical limitations of the Treaty. Enough time has passed since the last New START Treaty on-site inspection in March 2020 for Russia to have uploaded all or most of its strategic nuclear ballistic missiles.

Since 2000, the estimated number of women who have used the abortion pill mifepristone in the U.S. for “medical termination of pregnancy through the end of December 2022 is approximately 5.9 million women,” reported the Food and Drug Administration (FDA) earlier this month. This number represents potentially 5.9 million preborn human lives (at least) lost to abortion by the abortion pill regimen (mifepristone and misoprostol) since 2000, and is 300,000 more than what was previously reported in January through the end of June of 2022.